Back to Authors

Yefet, Leeor

Mayo Clinic

Mayo Clinic

Citations 2

ID #330 CNS tumor type prevalence according to age group: an analysis of 21,000 cases confirmed by methylation profiling, with a focus on adolescents and young adults
Fonseca, Adriana, Yefet, Leeor, Singh, Omkar, Dampier, Christopher, Dazelle, Karen , Lam, Michelle , Abdullaev, Zied , Chung, Hye-Jung, Quezado, Martha, Raffeld, M, Gagan, Jeffrey, Lee, Ina, Nasrallah, MacLean, Bennett, Julie, Bouffet, Eric, Poria, Dipak, Wesseling, Pieter, Bent, Martin Van den, Wen, Patrick, Varlet, Pascale, Tauziède-Espariat, Arnault, Cristiane, Ida, Zadeh, G Z, Aldape, Kenneth, Fonseca, Adriana , Yefet, Leeor S. , Singh, Omkar , Dampier, Christopher H. , Chung, Hye‐Jung, Quezado, Martha , Raffeld, Mark , Gagan, Jeffrey , Bouffet, Éric , Wesseling, Pieter , Bent, Martin J. van den , Varlet, Pascale , Tauziède-Espariat, Arnault , Ida, Cristiane M.

Neuro-Oncology Pediatrics | June 24, 2026 | Volume: 2 | Issue: Supplement_1 | Pages: No page available

10.1093/neuped/wuag026.102 Get It

Abstract Background Approximately 12,000 adolescents and young adults (ages 15-39, AYAs) are diagnosed with a primary central nervous system (CNS) tumor each year. DNA methylation profiling has transformed CNS tumor classification by refining diagnostic accuracy and identifying biologically distinct subtypes, but its application has not been systematically evaluated in the AYA population. In this study, we examined the spectrum of CNS tumor types across age groups, with a focus on the AYA population. Methods We assembled a large dataset of CNS tumor samples with age annotations and methylation profiles matching with high confidence to a CNS tumor type using the NCI/Bethesda classifier. Prevalence of tumor type, methylation class and DNA copy number aberrations were compared across age strata (pediatric, AYA and adult). Results The cohort of 21,099 CNS tumors included 5139 tumors from AYAs (24%), which showed a mixed pattern, with tumors typical of childhood (e.g. medulloblastoma) as well as those common in older adults (e.g. glioblastoma). Several tumor types were specifically enriched in the AYA, including IDH-mutant astrocytoma, pleomorphic xanthoastrocytoma, posterior fossa group B ependymoma, and diffuse hemispheric glioma, H3 G34-mutant, among others. Distinct methylation subclasses of multiple tumor types were observed in the AYA, and patterns of genomic aberrations showed age-specific distributions. Conclusion Large-scale methylation profiling revealed unique classification patterns of CNS tumors in AYAs, with specific tumor types, subclasses, and genomic alterations enriched in this population. These data may serve as a valuable reference resource for better understanding the spectrum of CNS tumors affecting AYA patients.
A Retrospective Evaluation of the Microsoft Healthcare Agent Orchestrator for Tumor Board Patient Summaries
Roy, Joy , Korleski, Jack , Augustin, Ryan Christian, Yefet, Leeor, Jensen, Zach D , Ehman, Eric C. , Zadeh, G Z, Conners, Amy Lynn , Tevaarwerk, Amye J, Korfiatis, Panagiotis, Yefet, Leeor S. , Tevaarwerk, Amyé , Korfiatis, Panagiotis

No container title available | June 1, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.05.22.26353812 Get It

Abstract Background Preparing tumor board patient summaries is time intensive. Large-language-model based systems may automate summarization but require real-world evaluation prior to clinical use. We performed an exploratory retrospective evaluation of the Microsoft Healthcare Agent Orchestrator (HAO), deployed in a Mayo Clinic–controlled staged environment, to generate tumor board–style patient summaries from retrospective Electronic Health Record (EHR) notes. Methods HAO generated summaries for breast, hepatobiliary, and neuro-oncology tumor board cases using up to the most recent 1,000 clinical notes. Clinician reviewers evaluated outputs via REDCap surveys across perceived factuality, completeness, clarity/conciseness, temporal cohesion, comparative performance, safety, and clinical utility (0–4 Likert scale). Reviewers were permitted to query the HAO chat interface to address missing details. Automated factuality was assessed using TBFact (bidirectional entailment), reporting precision and recall against available reference summaries. Results Among 57 survey responses from 5 different physicians, mean scores exceeded 2.8 across domains, with medians of 3 for most axes. In an exploratory comparison, oncology fellows required less time to review HAO-generated summaries than to manually generate patient summaries (mean difference 13.57 minutes per patient, p<0.001), although this difference may be influenced by prior familiarity with the same cases; 96% of survey responses indicated that HAO would save time. TBFact evaluations showed higher recall than precision across domains, consistent with broad capture of reference content alongside additional content that was not present in gold-standard summaries. Attribution was viewed favorably but showed issues with primary-source specificity and link reliability. Conclusions In a controlled Mayo environment, HAO demonstrated moderate performance and was associated with reduced review time for tumor board preparation. These findings are promising but preliminary and do not establish clinical safety, noninferiority to manual review, or readiness for routine clinical use. Limitations, including verbosity, specialty-specific content gaps, and inconsistent attribution, highlight the need for iterative refinement and further evaluation. Graphical Abstract Created using ChatGPT